Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immage Biotherapeutics Corp. (IMMG)
OTHER OTC:IMMG
Immage Biotherapeutics (IMMG) Stock Price & Analysis
0 Followers
IMMG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume1.00K
Average Volume (3M)N/A
Market Cap
$152.00
Enterprise Value-$53.53K
Total Cash (Recent Filing)$53.69K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)N/A
Beta-16.96
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding151,744,566
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation33.58
R-Squared0.02
Alpha11.08
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IMMG FAQ
What was Immage Biotherapeutics Corp.’s price range in the past 12 months?
Currently, no data Available
What is Immage Biotherapeutics Corp.’s market cap?
Currently, no data Available
When is Immage Biotherapeutics Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Immage Biotherapeutics Corp.’s earnings last quarter?
Currently, no data Available
Is Immage Biotherapeutics Corp. overvalued?
According to Wall Street analysts Immage Biotherapeutics Corp.’s price is currently Overvalued.
Does Immage Biotherapeutics Corp. pay dividends?
Immage Biotherapeutics Corp. does not currently pay dividends.
What is Immage Biotherapeutics Corp.’s EPS estimate?
Immage Biotherapeutics Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immage Biotherapeutics Corp. have?
Immage Biotherapeutics Corp. has 151,745,000 shares outstanding.
What happened to Immage Biotherapeutics Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Immage Biotherapeutics Corp.?
Currently, no hedge funds are holding shares in IMMG
---
Company Description
Immage Biotherapeutics Corp.
Immage Biotherapeutics Corp. is a biotechnology company, which develops novel immunotherapy biologics to treat various cancers. It develops, markets, and licenses its patented immunotherapy candidate for MAGE A. It encompasses vaccines, oncolytic viruses, adjuvants, and adoptive t-cell technologies. The company was founded by Anton Dormer and Mahesh Narayanan on June 21, 2012 and is headquartered in Bethesda, MD.
---
---